ZAI LAB LIMITED - AMER

Zai Lab Expands U.S. Operations to Join the Cambridge Biotechnology Community

16 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Zai Lab Announces Breakthrough Therapy Designation Granted for Bemarituzumab (FPA144) in China

14 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Zai Lab to Host Virtual Research and Development Day on September 22, 2021

09 Sep 2021 07:30:01 By Nasdaq GlobeNewswire

Zai Lab Announces Upcoming Presentations in September Investor Conferences

24 Aug 2021 07:30:00 By Nasdaq GlobeNewswire

Zai Lab Announces Second Quarter 2021 Financial Results and Corporate Updates

09 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

Schrödinger and Zai Lab Announce a Global R&D Collaboration in Oncology

04 Aug 2021 07:30:00 By Nasdaq GlobeNewswire

Zai Lab to Announce Second Quarter 2021 Financial Results

22 Jul 2021 07:30:00 By Nasdaq GlobeNewswire

Zai Lab and MacroGenics Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology

16 Jun 2021 07:30:00 By Nasdaq GlobeNewswire

Mirati Therapeutics and Zai Lab Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater China

01 Jun 2021 07:30:00 By Nasdaq GlobeNewswire

Zai Lab Announces First Patient Treated in China in the Registrational Phase 2 TRIDENT-1 Study of Repotrectinib

28 May 2021 07:30:00 By Nasdaq GlobeNewswire

Zai Lab Announces Upcoming Presentations in June Investor Conferences

25 May 2021 07:30:00 By Nasdaq GlobeNewswire

Zai Lab Announces First Patient Treated in Greater China in METIS Phase 3 Pivotal Trial of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer

24 May 2021 09:21:16 By Nasdaq GlobeNewswire

Zai Lab Announces First Quarter 2021 Financial Results

10 May 2021 07:32:50 By Nasdaq GlobeNewswire

Zai Lab to Announce First Quarter 2021 Financial Results on May 10, 2021

26 Apr 2021 07:30:00 By Nasdaq GlobeNewswire

Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option

23 Apr 2021 10:49:50 By Nasdaq GlobeNewswire

Zai Lab Announces Pricing of Public Offering of American Depositary Shares and Ordinary Shares

20 Apr 2021 19:40:00 By Nasdaq GlobeNewswire

Zai Lab Announces Proposed Public Offering of American Depositary Shares

19 Apr 2021 16:05:00 By Nasdaq GlobeNewswire

Zai Lab Partner Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer

13 Apr 2021 07:37:22 By Nasdaq GlobeNewswire

China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST)

31 Mar 2021 04:57:38 By Nasdaq GlobeNewswire

Zai Lab Announces Financial Results for Second-half and Full-year 2020

01 Mar 2021 07:00:01 By Nasdaq GlobeNewswire